NCT00407251View on ClinicalTrials.gov

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2010

Conditions

Hormone Refractory Prostate Cancer

Interventions

DRUG

Patupilone

Trial Locations (5)

T4N 4N2

Tom Baker Cancer Centre, Calgary

V5Z 4E6

BC Cancer Agency - Vancouver Centre, Vancouver

L8B 5C2

Juravinski Cancer Centre, Hamilton

N6A 4L6

London Health Sciences Centre, London

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors

lead

British Columbia Cancer Agency

OTHER

NCT00407251 - Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy | Biotech Hunter | Biotech Hunter